Sign in

Florian Naudet

@floriannaudet.bsky.social
2.6K followers 3.5K following 1.1K posts

Meta-researcher, Clinician, Professor at Rennes University, Senior member at Institut Universitaire de France, affiliate at METRICStanford. ORCID: 0000-0003-3760-3801 Posts are my own. Website: restores.univ-rennes.fr

PostsRepliesMedia
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 13h
Ooops, here is the link: mmmdata.io/posts/2025/0...
mmmdata.io
If researchers find Cohen's *d* = 8, no they didn't
I’ve spent a lot of time thinking about the plausibility of standardized effect sizes in the last year. From a trustworthiness assessment perspective, (standardized) effect sizes have a great combinat...
062
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 14h
See this excellent blog by @ianhussey.mmmdata.io for background on implausible effect sizes, including the reference to the 🍫 vs. 💩 study. We thought of including this comparison in the paper but did not, in order to avoid being all too provocative and rejected
131
Florian Naudet @floriannaudet.bsky.social · 15h
🍫 or 💩? About the effect size reported in a trial that shaped the estimated effect of fluoxetine in meta-analyses of pediatric depression, my stellar co-author @ploederl.bsky.social says: “It’s the kind of effect size you only get if you ask people whether they prefer chocolate or faeces.” 👇👇👇
nature.com
Prozac use for childhood depression skewed by single flawed medical trial
One small study in Iran swayed meta-analyses in favour of antidepressant use in children, researchers say.
184
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 02/10/2026
Thanks, Erick!
021
Reposted by Florian Naudet
Erick Turner @eturnermd1.bsky.social · 02/10/2026
Excellent work by @ploederl.bsky.social , @floriannaudet.bsky.social & colleagues. There had bn 2 NMAs published in @thelancet.com on meds 4 pediatric depression reporting o'all SMDs that seemed 2 good 2 B true, then found the culprit–an outlier with an SMD>4! onlinelibrary.wiley.com/doi/10.1002/...
onlinelibrary.wiley.com
A Re‐Appraisal of Three Network Meta‐Analyses to Explain the Discrepancy in Findings for the Efficacy of Fluoxetine for the Treatment of Depression in Children and Adolescents
Objective To explain discrepant findings for fluoxetine's efficacy in three influential network meta-analyses (NMAs) of treatments for pediatric depression, which led to conflicting clinical recomme...
162
Reposted by Florian Naudet
Jacek Debiec, MD, PhD, DPhil 🌎 🧠 @drjacekdebiec.bsky.social · 19h
Congrats!
021
Florian Naudet @floriannaudet.bsky.social · 02/10/2026
🔥 OUR STUDY FEATURED IN NATURE NEWS What if one flawed zombie trial 🧟 helped shape the evidence for treating depression in children? Quote : "Elia Abi-Jaoude, [...] calls the paper a “slam-dunk study”. “I hope it will get wide exposure” he says."
32512
Reposted by Florian Naudet
Richard Van Noorden @richvn.bsky.social · 02/10/2026
@floriannaudet.bsky.social, @ploederl.bsky.social and others found the change comes down to whether the meta-analyses happend to include a particular clinical trial on 40 children in Iran from 2006. This one trial found an unfeasibly huge advantage for Prozac over another antidepressant.
152
Reposted by Florian Naudet
Richard Van Noorden @richvn.bsky.social · 02/10/2026
Scientists have repeatedly warned that flawed studies are affecting the results of systematic reviews in medicine and other fields, but it’s rare to find such a clear example, says @floriannaudet.bsky.social . Read more here: www.nature.com/articles/d41...
nature.com
Prozac use for childhood depression skewed by single flawed medical trial
One small study in Iran swayed meta-analyses in favour of antidepressant use in children, researchers say.
1183
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 01/10/2026
🚨 Paper Alert 🚨 Our new study on the impact of a single small zombie trial on fluoxetine's overall efficacy estimation is out. With great colleagues @floriannaudet.bsky.social @richlyus.bsky.social and Gert van Valkenhoef 🧟‍♂️🧟‍♀️🧟 A longer 🧵 (1/n)
onlinelibrary.wiley.com
A Re‐Appraisal of Three Network Meta‐Analyses to Explain the Discrepancy in Findings for the Efficacy of Fluoxetine for the Treatment of Depression in Children and Adolescents
Objective To explain discrepant findings for fluoxetine's efficacy in three influential network meta-analyses (NMAs) of treatments for pediatric depression, which led to conflicting clinical recomme.....
2107
Reposted by Florian Naudet
Ian Hussey @ianhussey.mmmdata.io · 25/09/2026
"Systematic reviews are only as credible as the studies they include" INSPECT-SR was published yesterday, giving concrete guidance on how to exclude untrustworthy studies. Cochrane's statement: www.cochrane.org/about-us/new... Article: www.cochrane.org/about-us/new... Guidance: inspect-sr.com
cochrane.org
New tool helps researchers spot problematic trials before they distort evidence | Cochrane
26031
Reposted by Florian Naudet
Peer Review Congress #PRC11 Coming 2029! @peerreviewcongress.bsky.social · 21/09/2026
High-confidence MAs use prospectively reg’d protocols, independent reviewers, high-qual RCTs, w enough events for precise meaningful estimates w consistent effects + heterogeneity that's low or clinically/statistically explicable www.thelancet.com/jo... Harlan M. Krumholz The Lancet
022
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 20/09/2026
Just came across this meta-analysis on antidepressants to treat anxiety in elderly people. Have a look at the forest plot. Yes, the effects of some SSRI trials are implausibly large. Study: doi.org/10.1016/s221... Here an overview of the errors I detected: pubpeer.com/publications...
2112
Florian Naudet @floriannaudet.bsky.social · 04/09/2026
🚨 paper alert 🚨 « Open Science Policies and Practices Among Medical Journals » led by Constant Vinatier. jamanetwork.com/journals/jam...
jamanetwork.com
Open Science Policies and Practices Among Medical Journals
This cross-sectional study evaluates which open science practices have been adopted by leading general medical journals and whether automated tools can assess article-level adherence.
033
Reposted by Florian Naudet
rboussageon.bsky.social @rboussageon.bsky.social · 04/09/2026
www.jclinepi.com/article/S089... @floriannaudet.bsky.social
jclinepi.com
The erosion of proof in paradigm transitions: the rise of narrative rationality in health technology assessment
To describe and characterize three partly coexisting evidentiary configurations in drug regulation and health technology assessment (HTA), and to examine the inferential consequences of the progressiv...
031
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 04/09/2026
7. Posted on PubPeer: pubpeer.com/publications... M/SDs also appear to be GRIM/GRIMMER inconsistent, but this needs a more thorough check
pubpeer.com
PubPeer - Efficacy and safety evaluation of intravenous esketamine in...
There are comments on PubPeer for publication: Efficacy and safety evaluation of intravenous esketamine in alleviating perioperative depressive symptoms in Parkinson’s disease: a randomized controlled...
121
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 03/09/2026
1. Rant: with the help of BMC Journals, the literature is flooded with potentially fraudulent ketamine/esketamine studies. I just came across this one. SMD = 3.8 on day 7, when administered during anesthesia. Absurd!
link.springer.com
Efficacy and safety evaluation of intravenous esketamine in alleviating perioperative depressive symptoms in Parkinson’s disease: a randomized controlled trial - BMC Anesthesiology
Objective Depressive symptoms frequently afflict individuals with Parkinson’s disease (PD). The current study was consequently conducted to determine the efficacy of low-dose intravenous esketamine in...
2166
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 03/09/2026
2. Study says it followed the Helsinki Declaration, but it was registered retrospectively. The Helsinki Declaration requires prospective registration.
121
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 03/09/2026
3. "a recent large-scale meta-analysis (67 RCTs, n= 11,553) concluded that intravenous administration, the route used in our study, is the most effective for improving depressive symptoms and preventing postoperative depression, though it may carry a higher risk of dizziness [7]" Ref #7: mice study!
221
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 03/09/2026
4. Detected in about 30Minutes. I assume that many more oddities will occur when taking a closer look. @floriannaudet.bsky.social @ianhussey.mmmdata.io
121
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 03/09/2026
5. This is the p-value for the comparison of depression between esketamine and placebo at t3: 0.0000000000000000008 SMD = 3.77 (95% CI 2.88 to 4.67)
111
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 03/09/2026
6. "The trial protocol was prospectively registered with the Chinese Clinical Trial Registry" versus "An additional limitation of this study is the retrospective trial registration.when in fact it was done retrospectively"
142
Reposted by Florian Naudet
Jack Wilkinson @jdwilko.bsky.social · 03/09/2026
Research is so much more difficult when you care about research integrity. This is why it will never be a priority for most researchers. Researchers benefit from lax standards.
0113
Florian Naudet @floriannaudet.bsky.social · 27/08/2026
Peer review of the day: Is it possible that researchers pooled the baseline characteristics of clinical trials, thinking they were actually analyzing the efficacy of a treatment. and, on top of that, pooled the primary publication of a trial together with its secondary publications? Answer: YES
130
Reposted by Florian Naudet
Journal of Clinical Epidemiology @jclinepi.bsky.social · 24/08/2026
Choice of estimands and estimators affected the interpretation of results for some outcomes in a cluster-randomised trial (RESTORE) due to informative cluster size - Journal of Clinical Epidemiology www.jclinepi.com/article/S089...
jclinepi.com
Choice of estimands and estimators affected the interpretation of results for some outcomes in a cluster-randomised trial (RESTORE) due to informative cluster size
In cluster-randomised trials (CRTs), different estimands can be targeted, such as the individual- or cluster-average effect. These two estimands can differ in magnitude when outcomes or treatment effe...
045
Florian Naudet @floriannaudet.bsky.social · 24/08/2026
A new editorial (in French) published in La Revue de Médecine Interne by Alexandre Terré, Marie-France Mamzer and I, examines the avacopan (Tavneos®) case and the serious questions it raises about the integrity and oversight of clinical research. authors.elsevier.com/c/1nfgAubUqz...
132
Florian Naudet @floriannaudet.bsky.social · 24/08/2026
🚨 New preprint on nepotistic editors 🚨 How frequently do journal editors publish research articles in the journals they oversee? Our new preprint led by the great Cedric Lemarchand provides some interesting data from biomedical research. www.medrxiv.org/content/10.6...
medrxiv.org
Editors and research articles: a retrospective study of self-publication in biomedical research
Objective In 2021, a large-scale survey highlighted that in a subset of biomedical journals, a few authors –often serving on the editorial board– published disproportionately and experienced shorter a...
001
Florian Naudet @floriannaudet.bsky.social · 13/08/2026
New paper published in JCE: « The Erosion of Proof in Paradigm Transitions: The Rise of Narrative Rationality in Health Technology Assessment. » Lega JC, Gougeon A, Michal C, Provencher S, Naudet F, Falissard B, Chevrette C, Boussageon R jclinepi.com/retrieve/pii...
jclinepi.com
000
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 13/08/2026
🚨 1. Can changed trial characteristics explain fluoxetine's loss of efficacy for pediatric depression? New paper by @floriannaudet.bsky.social @richlyus.bsky.social and me is out. It is a secondary meta-regression on an already existing meta-analysis. Why was this important? ->
sciencedirect.com
Can fluoxetine’s diminished efficacy in pediatric depression be explained by study sites, baseline severity, age, and psychological interventions? A secondary exploratory meta-regression.
Fluoxetine’s efficacy estimates in pediatric depression trials have declined to the range of placebo equivalence. We investigated whether changes in t…
187
Reposted by Florian Naudet
Peer Review Congress #PRC11 Coming 2029! @peerreviewcongress.bsky.social · 12/08/2026
OSF is Changing! Starting Nov 16, 2026, no new projects or child components of existing projects can be created on OSF After Feb 19, 2027, all public and private OSF projects will become read-only Learn more at www.cos.io/osf-changes @cos.io @briannosek.bsky.social
cos.io
OSF Changes | Center for Open Science
We are preparing substantial changes to OSF that will reduce its functionality, focus OSF on its unique strengths, and move toward an integrated model with complementary services. As part of that shif...
021
Florian Naudet @floriannaudet.bsky.social · 11/08/2026
🔥 New SHARE-CTD paper in JCE co-led by the 2 brilliant Ka Hin Tai and Giulia Varvarà: Data sharing policies, requirements, and support from public and private clinical trial sponsors: a survey on top sponsors of clinical trials in Europe www.jclinepi.com/article/S089...
jclinepi.com
121
Florian Naudet @floriannaudet.bsky.social · 01/08/2026
Three reasons to be happy today. 1/ I'm on holiday (long overdue)... 🏝️
131
Reposted by Florian Naudet
Klabauterfrau vong durch den Wind 🦤 her @lieselotteluft.bsky.social · 28/07/2026
Wunderbar!
011
Florian Naudet @floriannaudet.bsky.social · 28/07/2026
Long day at work. Not the easiest one. Not the worst ever... Now it's evening, I'm back on the SHARE-CTD Datathon 2 writting, with some good music that reminds me of California. Not a bad way to end the day. The endless teaser continues... 😉 www.deezer.com/fr/album/130...
deezer.com
Dark Necessities
Red Hot Chili Peppers - album - 2016 - 1 titre
130
Reposted by Florian Naudet
Docdu16 @docdu16.eurosky.social · 25/07/2026
012
Florian Naudet @floriannaudet.bsky.social · 25/07/2026
New preprint led by Tala Jajieh from the ResToRes project. By analysing RCTs with confirmed data fabrication, our new preprint reveals that most zombie trials arise from monocentric, recurrent patterns of misconduct and often remain undetected for many years. www.medrxiv.org/content/10.6...
12511
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 23/07/2026
4. The editorial is IMO another example of wishful thinking in biological psychiatry, providing an outlook of finding moderators to allow precision psychiatry. There are many reasons for being humble here: bsky.app/profile/ploe...
022
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 23/07/2026
3. The editorial is about a individual patient meta-analysis of placebo-controlled trials (see thread below). This is the appropriate way to look at treatment effect heterogeneity. bsky.app/profile/ploe...
131
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 23/07/2026
2. For example, there is a reference to a study on the association (!) bw age and improvement of symptoms with antidepressants. A lot of causal interpretation. However, what is needed is to look at interactions between age and response to drug/placebo. www.sciencedirect.com/science/arti...
sciencedirect.com
The impact of age on antidepressant response: A mega-analysis of individuals with major depressive disorder
Understanding how age affects antidepressant response in patients with major depressive disorder has been complicated by small and heterogeneous studi…
131
Reposted by Florian Naudet
Global Research Initiative on Open Science (GRIOS) @grios-openscience.bsky.social · 22/07/2026
The GRIOS call for evidence synthesis on #OpenScience has now closed & the response exceeded our expectations. Thanks to all who submitted a proposal! Over 70 received, ~1/3 on incentives & research assessment, 2/3 on data sharing. Evaluation results expected: Nov 2026 www.grios.org/grios-first-...
grios.org
GRIOS first open call for evidence synthesis on Open Science has closed
The GRIOS open call for evidence synthesis on Open Science closed on 20 July 2026. We are grateful to all who submitted a proposal — the response has exceeded our expectations. Over 70 proposals we...
065
Reposted by Florian Naudet
Lesley Uttley @lesleyuttley.bsky.social · 20/07/2026
Our living review has now synthesised 846 articles examining problems with systematic reviews. Reporting improved in some areas, but persistent concerns remain around methodological quality, transparency, spin, conflicts of interest, and global representation. authors.elsevier.com/a/1nTHE3BcJQ...
authors.elsevier.com
Please wait whilst we redirect you
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
074
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 15/07/2026
11. Thanks to @floriannaudet.bsky.social and @richlyus.bsky.social for the excellent collaboration.
011
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 15/07/2026
10. Here's a graphical depiction of the outlying findings, when compared to other pediatric fluoxetine trials.
141
Reposted by Florian Naudet
Martin Plöderl @ploederl.bsky.social · 15/07/2026
1. We wrote a letter to the editor about this fluoxetine trial for children aged 4-6. Given the urgency and the expected delay in response, we also published it as a preprint, available here: doi.org/10.31234/osf... Which problems did we detect with this study ? 🧵
2138
Reposted by Florian Naudet
Dr. Lucky Tran @luckytran.com · 07/07/2026
Cheer up, USA. One of your soccer teams has won 4 World Cups.
Megan Rapinoe
6886991641
Reposted by Florian Naudet
Peer Review Congress #PRC11 Coming 2029! @peerreviewcongress.bsky.social · 26/06/2026
#TriNetX, which provides access to anonymized EHRs for >300M patients in the US & abroad, may be allowing inexperienced researchers potentially aided by #AI to churn out unreliable bias-ridden studies w unrivaled speed www.science.org/content/arti... @joelving.bsky.social @retractionwatch.com
science.org
Medical students are using a popular research tool to pump out misleading studies
Critics say TriNetX’s easy analyses of electronic medical records fuel quick-and-dirty publications from inexperienced authors
131
Reposted by Florian Naudet
SHARE CTD @sharectd.bsky.social · 16/06/2026
Huge congratulations to our fellow researcher @minoo-matbouriahi.bsky.social on her latest publication in JAMA Network Open! She teamed up with @floriannaudet.bsky.social John Ioannidis @ioanaacristea.bsky.social, and a stellar team to tackle a fascinating topic in #ResearchIntegrity #PeerOnSky
121
Florian Naudet @floriannaudet.bsky.social · 15/06/2026
Nice editorial in @bmj.com: "Influence on regulatory decisions for drugs with limited evidence" by Sahar Barjesteh van Waalwijk van Doorn-Khosrovani and Timothée Olivier "Conflicts of interest and political and emotional pressures are key challenges www.bmj.com/content/393/...
bmj.com
Influence on regulatory decisions for drugs with limited evidence
Conflicts of interest and political and emotional pressures are key challenges Regulatory agencies face growing pressure to approve drugs despite major safety and efficacy concerns. Over decades, th...
021
Reposted by Florian Naudet
Daniel E. Weeks @statgendan.bsky.social · 07/06/2026
“The combination of some data and an aching desire for an answer does not ensure that a reasonable answer can be extracted from a given body of data.” John Tukey
141
Reposted by Florian Naudet
Eiko Fried @eikofried.bsky.social · 07/06/2026
What a dream author team! Can’t wait to read.
021